Benign Prostatic Hyperplasia, or BPH, is a condition in which the prostate enlarges as men age. BPH is very common, affecting nearly 500 million men worldwide. More than 40% of men in their 50s and more than 70% of men in their 60s have BPH.1 While BPH is a benign condition and unrelated to prostate cancer, it can greatly affect a man's quality of life.
A wide variety of treatments are available for men with BPH, including medication, minimally invasive therapies, and surgery. You and your doctor will consider several factors when you evaluate these choices.
The International Prostate Symptom Score (IPSS) is a common method for screening and diagnosing benign prostatic hyperplasia (BPH). The survey asks seven urinary symptom questions and one quality of life question to help determine the severity of your BPH.
Get answers to more than 20 frequently asked questions about The UroLift System.